You are right I spelled Evolis wrongly. I should have proof read it before posting. Now let us ask the CEO to provide us with break downs on sales/revenues, costs and profits for individual branches, Australia/New Zealand, Japan and US. I am sure Japan contributes the highest revenues and profits and only entity that makes profit. Japan happens to be run independently, with CEO having little influence. Why do you think Cellmid management is reluctant to produce individual branch contributions? I and many more have asked for this information and have been consistently denied.
As for CEO being rewarded a bonus for making Advangen profitable is a big laugh. Obviously you have not been reading the various posts concerning this issue or your memory is very selective. Cellmid has never made any profit in its entire history.
